Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis.

Yeo CM, Chong VH, Earnest A, Yang WL.

World J Hepatol. 2013 May 27;5(5):275-80. doi: 10.4254/wjh.v5.i5.275.

PMID:
23717738
[PubMed]
Free PMC Article
2.

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.

Malatjalian DA, Ross JB, Williams CN, Colwell SJ, Eastwood BJ.

Can J Gastroenterol. 1996 Oct;10(6):369-75.

PMID:
9193771
[PubMed - indexed for MEDLINE]
3.

Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.

Langman G, Hall PM, Todd G.

J Gastroenterol Hepatol. 2001 Dec;16(12):1395-401.

PMID:
11851839
[PubMed - indexed for MEDLINE]
4.

Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.

Nyfors A.

Acta Pathol Microbiol Scand A. 1977 Jul;85(4):511-8.

PMID:
899789
[PubMed - indexed for MEDLINE]
5.

Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.

Boffa MJ, Chalmers RJ, Haboubi NY, Shomaf M, Mitchell DM.

Br J Dermatol. 1995 Nov;133(5):774-8.

PMID:
8555032
[PubMed - indexed for MEDLINE]
6.

The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.

vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.

Br J Dermatol. 1996 Mar;134(3):481-7.

PMID:
8731673
[PubMed - indexed for MEDLINE]
7.

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.

Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.

PMID:
19273538
[PubMed - indexed for MEDLINE]
Free Article
8.

Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.

Nyfors A, Poulsen H.

Acta Pathol Microbiol Scand A. 1976 May;84(3):262-70.

PMID:
1274591
[PubMed - indexed for MEDLINE]
9.

Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.

Rosenberg P, Urwitz H, Johannesson A, Ros AM, Lindholm J, Kinnman N, Hultcrantz R.

J Hepatol. 2007 Jun;46(6):1111-8. Epub 2007 Feb 15.

PMID:
17399848
[PubMed - indexed for MEDLINE]
10.

Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.

Boffa MJ, Smith A, Chalmers RJ, Mitchell DM, Rowan B, Warnes TW, Shomaf M, Haboubi NY.

Br J Dermatol. 1996 Oct;135(4):538-44.

PMID:
8915142
[PubMed - indexed for MEDLINE]
11.

Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.

Themido R, Loureiro M, Pecegueiro M, Brandão M, Campos MC.

Acta Derm Venereol. 1992 Sep;72(5):361-4.

PMID:
1361285
[PubMed - indexed for MEDLINE]
12.

Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.

Zachariae H, Søgaard H, Heickendorff L.

Dermatology. 1996;192(4):343-6.

PMID:
8864370
[PubMed - indexed for MEDLINE]
13.

The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.

Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH.

Arthritis Rheum. 1997 Dec;40(12):2226-34.

PMID:
9416861
[PubMed - indexed for MEDLINE]
14.

The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.

Zachariae H, Heickendorff L, Søgaard H.

Br J Dermatol. 2001 Jan;144(1):100-3.

PMID:
11167689
[PubMed - indexed for MEDLINE]
15.

Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?

Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J.

Liver Transpl. 2003 Nov;9(11):1152-8.

PMID:
14586875
[PubMed - indexed for MEDLINE]
Free Article
16.

The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis.

Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH.

J Pediatr. 1999 Jan;134(1):47-52.

PMID:
9880448
[PubMed - indexed for MEDLINE]
17.

Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.

Erickson AR, Reddy V, Vogelgesang SA, West SG.

Arthritis Rheum. 1995 Aug;38(8):1115-9.

PMID:
7639808
[PubMed - indexed for MEDLINE]
18.

Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

Aithal GP, Haugk B, Das S, Card T, Burt AD, Record CO.

Aliment Pharmacol Ther. 2004 Feb 15;19(4):391-9.

PMID:
14871278
[PubMed - indexed for MEDLINE]
Free Article
19.

Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.

Berends MA, Snoek J, de Jong EM, van de Kerkhof PC, van Oijen MG, van Krieken JH, Drenth JP.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):805-11.

PMID:
16918884
[PubMed - indexed for MEDLINE]
Free Article
20.

Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis.

Nohlgård C, Rubio CA, Kock Y, Hammar H.

J Am Acad Dermatol. 1993 Jan;28(1):40-5.

PMID:
7678843
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk